Binith Cheeran, MD, PhD
Advertisement
Senior Director of Medical and Clinical Affairs for Abbott’s Deep Brain Stimulation (DBS) products, a part of Abbott’s neuromodulation business.
Articles by Binith Cheeran, MD, PhD
Advertisement
Latest Updated Articles
Advance in Remote Care Benefits Movement Disorder PatientsPublished: February 14th 2022 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Phase 3 MG0020 Trial Highlights Success of Self-Administered Rozanolixizumab for Generalized Myasthenia Gravis
2
Efgartigimod Effective in Seronegative gMG, Obexelimab Meets Primary End Point, FDA Accepts NDA for Tau Tracer MK-6240
3
Evaluating Combined Supraorbital and Occipital Neuromodulation in Phase 3 Trial for Resistant Migraine: The RECLAIM Study
4
Newly Unveiled EPIC Trial Pins Myasthenia Gravis Medications Nipocalimab Against Efgartigimod for Efficacy
5
